Group 1 - The board of directors of Jingrui Electronic Materials Co., Ltd. held its eighth meeting of the fourth session, with all nine directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the 2025 semi-annual report and the special report on the use of raised funds, with unanimous support from all directors [2][3] - The company proposed a cash dividend of 0.10 yuan (including tax) per share based on the total share capital of 1,059,574,198 shares as of June 30, 2025, without capital reserve conversion or stock distribution [2][3] Group 2 - The board plans to hold a temporary shareholders' meeting on September 16, 2025, to review the proposals that require shareholder approval [4] - The company will adjust the total cash dividend amount if there are changes in total share capital before the implementation of the profit distribution plan, maintaining the distribution ratio [2][3]

Core Points - The document outlines the management system for foreign exchange derivative trading at Guangbo Group Co., Ltd, aiming to standardize operations and enhance risk management [1][2][3] Group 1: General Principles - The foreign exchange derivative trading is defined as transactions aimed at mitigating exchange rate or interest rate risks based on the company's foreign currency payment and receipt needs [1] - The trading activities must comply with national laws and regulations, adhering to principles of legality, prudence, safety, and effectiveness [2][3] - The company is prohibited from engaging in speculative or illegal arbitrage trading [2] Group 2: Trading Approval Authority - The management must provide a feasibility analysis report for derivative trading, which requires board approval before execution [3][4] - If the expected margin and premium exceed 50% of the latest audited net profit or 5 million RMB, shareholder approval is also required [4] - Any derivative trading that exceeds board authority must be approved by the shareholders' meeting [4][5] Group 3: Management and Implementation - The finance department is responsible for the implementation and management of foreign exchange derivative trading, ensuring compliance with internal control systems [6][7] - The finance department must establish appropriate stop-loss limits and procedures for different types of derivatives [6][7] - Regular audits and checks on the progress of derivative trading projects are mandated to ensure compliance and risk management [7][8] Group 4: Information Disclosure - The company is required to disclose relevant information regarding foreign exchange derivative activities in accordance with regulations from the China Securities Regulatory Commission and the Shenzhen Stock Exchange [7][8] - The board must continuously monitor the execution and safety of derivative trading, taking immediate action in case of significant losses [7]

天马微电子股份有限公司 外汇衍生品交易业务管理制度 第三条 公司开展外汇衍生品交易业务只允许与经国家外汇管理总局和中 国人民银行批准、具有外汇衍生品交易业务经营资格的金融机构进行交易，不得 与前述金融机构之外的其他组织或个人进行交易。 第四条 公司进行外汇衍生品交易必须基于公司的外币收（付）款的谨慎预 测，外汇衍生品交易合约的外币金额不得超过外币收（付）款的谨慎预测量。外 汇衍生品交易的交割期间需与公司预测的外币回款时间相匹配，持仓时间一般不 得超过 12 个月或实货合同规定时间。 （2025 年 8 月修订） 第一章 总 则 为规范天马微电子股份有限公司（以下简称"公司"）外汇衍生品交易业务及 相关信息披露工作，加强对外汇衍生品交易业务的管理，防范投资风险，健全和 完善公司外汇衍生品交易业务管理机制，确保公司资产安全，根据《中华人民共 和国公司法》《中华人民共和国证券法》《深圳证券交易所股票上市规则》《上 市公司信息披露管理办法》及《公司章程》等有关规定，结合公司实际情况，特 制定本制度。 第一条 本制度所指外汇衍生品业务主要是以汇率为标的资产的远期合约、 掉期业务为套期工具，旨在为降低主业范围内风险敞口而 ...

2025年8月21日，中际联合（北京）科技股份有限公司召开会议，审议通过《关于增加外汇衍生品交易 业务额度的议案》，该议案尚需股东会审议。公司拟将外汇衍生品交易额度由不超3500万美元（或其他 等值外币）增至不超1.25亿美元（或其他等值外币），额度内公司及子公司可共同循环滚动使用，资金 为自有资金。 ...

第一条 为规范山东潍坊润丰化工股份有限公司（以下简称 "公司"）外汇 衍生品交易业务及相关信息披露工作，加强对外汇衍生品交易业务的管理，防范 投资风险，健全和完善公司外汇衍生品交易业务管理机制，确保公司资产安全， 根据《中华人民共和国公司法》《中华人民共和国证券法》《中华人民共和国外 汇管理条例》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公 司自律监管指引第 2 号——创业板上市公司规范运作》以及《公司章程》等有关 规定，结合公司实际情况，特制定本制度。 第二条 本制度所称的外汇衍生品交易业务是指为满足正常经营和业务需要， 与具有相关业务经营资质的银行等金融机构开展的用于规避及防范汇率或利率 风险的各项业务，包括但不限于远期结售汇、外汇掉期、外汇期权、利率互换、 利率掉期等产品或者混合上述产品特征的金融工具。 第三条 本制度适用于公司及子公司的外汇衍生品交易业务。未经公司同意， 公司下属子公司不得进行外汇衍生品交易业务。同时，公司应当按照本制度的有 关规定，履行有关决策程序和信息披露义务。 第二章 外汇衍生品交易业务的操作原则及操作流程 第四条 公司进行外汇衍生品交易业务应遵循合法、审慎、安全、 ...

Core Viewpoint - The company, Guangdong Guokang Biochemical Technology Co., Ltd., aims to continue its foreign exchange derivatives trading to mitigate risks associated with currency fluctuations and enhance financial stability [1][10]. Group 1: Purpose of Foreign Exchange Derivatives Trading - The primary objective of engaging in foreign exchange derivatives trading is to effectively hedge against foreign exchange market risks and prevent adverse impacts from significant currency fluctuations [1]. - The company plans to engage with qualified banks and financial institutions to conduct these transactions [1]. Group 2: Basic Details of the Trading Business - The company intends to utilize its own funds for foreign exchange derivatives trading, with a total limit not exceeding $50 million [2]. - The expected maximum margin and premium for these transactions will not exceed $4 million [2]. - The trading will involve currencies used in the company's overseas operations, primarily the US dollar, and will include various products such as forward foreign exchange settlements, foreign exchange swaps, and options [1][2]. Group 3: Risk Management Measures - The company will adhere to principles of legality, prudence, safety, and effectiveness in its trading activities, avoiding speculative transactions [4][8]. - A clear set of operational norms, approval authorities, and risk management procedures will be established to control trading risks [8]. Group 4: Impact on the Company - The foreign exchange derivatives trading is closely related to the company's operational activities, enhancing its ability to manage foreign exchange risks and reducing financial costs [5][10]. - The trading activities are expected to strengthen the company's financial stability without harming the interests of the company or its shareholders [5][10]. Group 5: Accounting Policies and Procedures - The company will follow relevant accounting standards for financial instruments and hedge accounting to reflect the transactions in its financial statements [9]. Group 6: Approval Process - The board of directors approved the continuation of foreign exchange derivatives trading on August 20, 2025, with the authorization effective from September 23, 2025, for a period of 12 months [9][10]. - The audit committee has confirmed the necessity and compliance of the decision-making process regarding the trading activities [10].

2025年8月20日，广康生化（300804）召开会议，审议通过继续开展外汇衍生品交易业务议案。鉴于前 次额度授权9月23日到期，公司及子公司拟用自有资金开展总额度不超5000万美元业务，授权自9月23日 起生效，有效期12个月，资金可循环使用。交易涉及主要外币为美元，方式包括远期结售汇等。业务存 在市场、汇率波动等风险，公司制定了相应管理措施。该业务与经营紧密相关，能增强财务稳健性，已 获董事会、审计委员会通过，保荐人无异议。 ...

Core Viewpoint - The company has approved a plan to engage in foreign exchange derivative hedging to mitigate risks associated with currency fluctuations, enhancing financial stability while ensuring that core business operations remain unaffected [3][12][25]. Group 1: Board Meeting Details - The company's 25th meeting of the 8th Board of Directors was held on August 19, 2025, with all 9 directors present, confirming the legality and validity of the meeting [2][3]. - The board unanimously approved the proposal for foreign exchange derivative hedging with a vote of 9 in favor, 0 against, and 0 abstentions [3][4]. Group 2: Foreign Exchange Derivative Hedging Proposal - The company plans to conduct foreign exchange derivative hedging with a maximum transaction amount of up to $80 million or equivalent foreign currency, which can be rolled over within a 12-month period [3][12][15]. - The hedging activities are aimed at preventing adverse impacts from foreign currency exchange rate fluctuations and enhancing the company's financial resilience [12][14]. Group 3: Monitoring and Risk Management - The company has established a comprehensive risk management framework to monitor foreign exchange market conditions and adjust strategies accordingly to minimize potential losses [22]. - The financial department will oversee all foreign exchange derivative transactions, ensuring they are based on actual business needs and not speculative in nature [22][23]. Group 4: Compliance and Approval Process - The proposal for foreign exchange derivative hedging was reviewed and approved by both the Board of Directors and the Supervisory Board, confirming compliance with relevant laws and regulations [19][20][25]. - The company has developed a specific management system for foreign exchange derivative transactions to ensure adherence to regulatory requirements and internal controls [4][25].

证券代码：688620 证券简称：安凯微 公告编号：2025-044 广州安凯微电子股份有限公司 第二届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 广州安凯微电子股份有限公司（以下简称"公司"）第二届董事会第十四次会 议于 2025 年 8 月 12 日 10:30-11:00 在公司会议室以现场与通讯相结合的方式召开。 本次会议的通知已于 2025 年 8 月 1 日以通讯方式送达公司全体董事。本次会议由公 司董事长 NORMAN SHENGFA HU（胡胜发）[以下简称"胡胜发"]先生主持，会 议应出席董事 7 名，实际出席董事 7 名。本次会议的召集、召开和表决程序符合 《中华人民共和国公司法》（以下简称"《公司法》"）等法律、法规、规范性文件 和《广州安凯微电子股份有限公司章程》（以下简称"《公司章程》"）、《广州安凯 微电子股份有限公司董事会议事规则》的规定，会议决议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于2025年半年度报告及其摘要的议案 ...

国泰海通证券股份有限公司关于广州安凯微电子股份有限 公司开展外汇衍生品交易业务的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐人"）作为广 州安凯微电子股份有限公司（以下简称"安凯微"或"公司"）首次公开发行股 票并在科创板上市的持续督导保荐人，根据《上海证券交易所上市公司自律监管 指引第11号——持续督导》《上海证券交易所科创板股票上市规则》《上海证券 交易所科创板上市公司自律监管指引第1号——规范运作》等有关规定，对公司 拟开展的外汇衍生品交易业务进行了审慎核查，发表核查意见如下： 一、交易概况 （一）交易目的 随着公司业务规模持续扩大，日常外汇收支金额日益增长。当前受国际政治、 经济变化等因素综合影响，外汇市场波动幅度较大。为有效规避和防范汇率风险 或利率风险，增强公司财务稳健性，公司及子公司拟继续开展外汇衍生品交易业 务。 （二）交易额度 根据公司的经营预算，公司拟开展总额度不超过1,000万美元（含等值外币） 的外汇衍生品交易，预计使用的交易保证金和权利金总额度上限不超过1,000万 美元（含等值外币），自第二届董事会第十四次会议审议通过之日起12个月内有 效，开展期限内任一时点的 ...